JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma

Clinical and Translational Oncology

Volumn 14, Issue 2, 2012, Pages 143-149

  You, Zhenbing ^a   Xu, Dafu ^a   Ji, Jian ^a   Guo, Wei ^a   Zhu, Weiguo ^a   He, Jingdong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

JAK STAT pathway; Oesophageal squamous cell carcinoma; Prognosis

Indexed keywords

JANUS KINASE 1; STAT3 PROTEIN;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOMA CELL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TRANSCRIPTION INITIATION;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; JANUS KINASE 1; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHORYLATION; PROGNOSIS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SURVIVAL RATE;

EID: 84860733964     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0774-6     Document Type: Article

References (30)

1. Jiang H, Gong M, Cui Y et al (2010) Upregulation of caspase-3 expression in esophageal cancer correlates with favorable prognosis: an immunohistochemical study from a high incidence area in northern China. Dis Esophagus 23:487-492
2. Wang WS, Zhong HJ, Xiao DW et al (2010) The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. Dis Esophagus 23:512-521
3. Delektorskaya VV, Chemeris GY, Kononets PV et al (2009) Clinical signifi cance of hyperexpression of epidermal growth factor receptors (EGFR and HER-2) in esophageal squamous cell carcinoma. Bull Exp Biol Med 148:241-245
4. Sano A, Sakurai S, Kato H et al (2009) Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma. Anticancer Res 29:3375-3380
5. Kato H, Fukuchi M, Miyazaki T (2007) Surgical treatment for esophageal cancer. Current issues. Dig Surg 24:88-95
6. Bolli R, Dawn B, Xuan YT (2003) Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med 13:72-79 (Pubitemid 36175531)
7. Booz GW, Day JN, Baker KM (2002) Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34:1443-1453 (Pubitemid 35373667)
8. Gross ER, Hsu AK, Gross GJ (2006) The JAK/ STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT-3, Akt, and GSK-3ß. Am J Physiol Heart Circ Physiol 291:827-834
9. Kandalam U, Clark MA (2010) Angiotensin II activates JAK2/STAT-3 pathway and induces interleukin- 6 production in cultured rat brainstem astrocytes. Regul Pept 159:110-116
10. Darnell JE Jr (1997) STATs and gene regulation. Science 277:1630-1635 (Pubitemid 27446219)
11. Levy DE, Darnell JE Jr (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662 (Pubitemid 34987786)
12. Calo V, Migliavacca M, Bazan V (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197:157-168 (Pubitemid 37485244)
13. Bromberg JF (2001) Activation of STAT proteins and growth control. Bioessays 23:161-169 (Pubitemid 32116649)
14. Williams JG (2000) STAT signaling in cell proliferation and in development. Curr Opin Genet Dev 10:503-507
15. Valdembri D, Serini G, Vacca A (2002) In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J 16:225-227
16. Tu Y, Zhong Y, Fu J et al (2011) Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas. Med Oncol 28:15-23
17. Tam L, McGlynn LM, Traynor P et al (2007) Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer. Br J Cancer 97:378-383 (Pubitemid 47196744)
18. Hamilton S, Aaltonen L (2000) World Health Organization classifi cation of tumors. Pathology and genetics of tumors of the digestive system. IARC, Lyon
19. Gao B, Shen XN, Kunos G (2001) Constitutive activation of JAK-STAT-3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett 488:179-184 (Pubitemid 32103593)
20. Song JI, Rubin Grandis J (2000) STAT signaling in head and neck cancer. Oncogene 19:2489-2495 (Pubitemid 30339204)
21. Huang M, Page C, Reynolds RK (2000) Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 79:67-73
22. Campbell CL, Jiang Z, Savarese DM (2001) Increased expression of the interleukin-11 receptor and evidence of Stat3 activation in prostate carcinoma. Am J Pathol 158:25-32 (Pubitemid 32096467)
23. Berclaz G, Altermatt HJ, Rohrbach V (2001) EGFR dependent expression of Stat3 (but not STAT1) in breast cancer. Int J Oncol 19:1155-1160
24. Page C, Huang M, Jin X (2000) Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells. Int J Oncol 17:23-28
25. Wei L, Kuo ML, Chen CA (2003) Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22:1517-1527 (Pubitemid 36390601)
26. Turkson J (2004) STAT proteins as novel targets for cancer drug discovery. Exp Opin Ther Targets 5:409-422 (Pubitemid 39359648)
27. Turkson J, Tammy Bowman T, Garcia R et al (1998) Stat3 activation by Src induces specifi c gene regulation and is required for cell transformation. Mol Cell Biol 18:2545-2552 (Pubitemid 28183424)
28. Haura EB, Turkson J, Jove R (2005) Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2:315-324 (Pubitemid 40903176)
29. Wang T, Niu G, Kortylewski M (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10:48-54 (Pubitemid 38524698)
30. Niu G, Wright KL, Huang M (2002) Constitutive STAT3 activity up-regulates VEGF expression in tumor angiogenesis. Oncogene 21:2000-2008 (Pubitemid 34270888)